No evidence in favor of a more deleterious impact of a major depressive episode on verbal memory in older patients with antidepressant response

被引:0
|
作者
Blandin, Elise [1 ,2 ]
Carle, Guilhem [3 ]
Theuil, Benoit [4 ]
Katz, Julien [5 ]
Gorwood, Philip [1 ,2 ]
机构
[1] Univ Paris 05, CMME Grp Hosp St Anne, Paris, France
[2] INSERM, Ctr Psychiat & Neurosci, U894, F-75014 Paris, France
[3] Sect 17 Ctr Hosp St Anne, F-75014 Paris, France
[4] SHU Grp Hosp St Anne, F-75014 Paris, France
[5] Hop H Mondor A Chenevier, AP HP, Pole Psychiat, F-94000 Paris, France
关键词
depressive episodes; memory impairment; elderly patients; neurotoxicity; age; lifetime; HIPPOCAMPAL VOLUME; DISORDER; LIFE; DYSFUNCTION; IMPAIRMENT; SYMPTOMS; DEMENTIA; THERAPY; RISK;
D O I
10.1017/S1041610215000228
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Older patients may be more vulnerable to the deleterious effect of depressive episodes on delayed narrative memory, a cognitive task which reflects hippocampal activity. We aimed to disentangle which factors could explain such increased vulnerability in the elderly, including the poorer response to treatment, a longer lifetime exposure to past depressive episodes, and lower baseline memory skills. Methods: From an initial sample of 8,229 depressed outpatients, we focused on the 2,424 treatment responders, and compared older (65 years old and over, N = 233) to younger (N= 2,191) ones. These patients were included through general practitioners' assessment and tested for the Wechsler delayed paragraph recall index, a valid and sensitive test assessing verbal declarative memory (and a marker of the hippocampal function), at baseline and after six weeks of treatment. Results: As expected, older patients after response to antidepressants showed decreased narrative memory abilities compared to younger ones. As baseline memory performance and residual depressive symptoms were also found in excess in this sample, they could act as confounders. Indeed, after controlling for these two factors, the role of age in memory performance after treatment response was ruled out. Conclusions: The potential "toxicity" of a depressive episode to cognitive functions related to the hippocampus may not be more critical in older patients compared to younger ones. Limiting remaining depressive symptoms in older depressed patients might be a way to counteract the observed worsening of memory functions in depressed patients.
引用
收藏
页码:1477 / 1484
页数:8
相关论文
共 50 条
  • [31] Acute working memory improvement after tDCS in antidepressant-free patients with major depressive disorder
    Oliveira, Janaina F.
    Zanao, Tamires A.
    Valiengo, Leandro
    Lotufo, Paulo A.
    Bensenor, Isabela M.
    Fregni, Felipe
    Brunoni, Andre R.
    NEUROSCIENCE LETTERS, 2013, 537 : 60 - 64
  • [32] Impact of pharmacist intervention on antidepressant medication adherence and disease severity in patients with major depressive disorder
    Yusuf, H.
    Magaji, M. G.
    Maiha, B. B.
    Yakubu, S. I.
    Wazis, H. C.
    Mohammed, S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 : 193 - 193
  • [33] The Impact of Antidepressant-Associated Sexual Dysfunction on Treatment Adherence in Patients with Major Depressive Disorder
    Clayton, Anita H.
    CURRENT PSYCHIATRY REVIEWS, 2013, 9 (04) : 293 - 301
  • [34] Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder
    Bobo, William, V
    Van Ommeren, Bailey
    Athreya, Arjun P.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 927 - 944
  • [35] C-reactive protein, antidepressant treatment response and insulin level in major depressive patients
    Chang, Hui Hua
    Chen, Po See
    Gean, Po Wu
    DRUG METABOLISM REVIEWS, 2011, 43 : 36 - 36
  • [36] Effects of adjunctive aripiprazole in patients with major depressive disorder with inadequate response to standard antidepressant therapy
    Lee, J. S.
    Kim, S. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S865 - S866
  • [37] Neural correlates of antidepressant response to escitalopram in patients with major depressive disorder: A preliminary fMRI study
    Takamura, M.
    Okamoto, Y.
    Okada, G.
    Toki, S.
    Yamamoto, T.
    Matsumoto, T.
    Yamawaki, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 123 - 123
  • [38] Effect of Antidepressant Treatment on 5-HT4 Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
    Dam, Vibeke H.
    Koehler-Forsberg, Kristin
    Ozenne, Brice
    V. Larsen, Soren
    Ip, Cheng-Teng
    Jorgensen, Anders
    Stenbaek, Dea S.
    Madsen, Jacob
    Svarer, Claus
    Jorgensen, Martin B.
    Knudsen, Gitte M.
    Frokjaer, Vibe G.
    BIOLOGICAL PSYCHIATRY, 2025, 97 (03) : 261 - 268
  • [39] Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years
    Wagner, Stefanie
    Wollschlaeger, Daniel
    Dreimueller, Nadine
    Engelmann, Jan
    Herzog, David P.
    Roll, Sibylle C.
    Tadic, Andre
    Lieb, Klaus
    COMPREHENSIVE PSYCHIATRY, 2020, 99
  • [40] Predictors of 4-week antidepressant outcome in patients with first-episode major depressive disorder: An ROC curve analysis
    Zhou, Yanling
    Zhang, Zhipei
    Wang, ChengYu
    Lan, Xiaofeng
    Li, Weicheng
    Zhang, Muqin
    Lao, Guohui
    Wu, Kai
    Chen, Jun
    Li, Guixiang
    Ning, Yuping
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 304 : 59 - 65